Alok Srivastava
- Hematology top 0.02%
- Hemophilia Treatment and Research 106
- Hematopoietic Stem Cell Transplantation 68
- Platelet Disorders and Treatments 57
- Acute Myeloid Leukemia Research 50
- Blood Coagulation and Thrombosis Mechanisms 50
- Chronic Myeloid Leukemia Treatments 33
- Genetics top 0.2%
- Hemoglobinopathies and Related Disorders 47
- Internal Medicine top 1%
- Biochemistry top 2%
- Transplantation top 2%
-
- Acute Lymphoblastic Leukemia research 36
- Co-authors
- Mammen ChandyVikram MathewsBiju GeorgeNigel S. KeyJohnny MahlanguShaji R VelayudhanAuro ViswabandyaAdolfo Llinás
- Cited by
- HematologyGeneticsInternal Medicine
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- IndiaUnited StatesCanada
In The Last Decade
Alok Srivastava
387 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Hematology 8.0k
- Genetics 2.2k
- Internal Medicine 312
- Biochemistry 302
- Transplantation 125
Countries citing papers authored by Alok Srivastava
This map shows the geographic impact of Alok Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok Srivastava more than expected).
Fields of papers citing papers by Alok Srivastava
This network shows the impact of papers produced by Alok Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok Srivastava. The network helps show where Alok Srivastava may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alok Srivastava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2017 | 38 | |
| 18 | 2015 | 1 | |
| 19 | 2015 | 0 | |
| 20 | Transfusion associated HIV infection in patients with haematologic disorders in southern India. | 1994 | 7 |
About Alok Srivastava
Alok Srivastava is a scholar working on Hematology, Genetics and Transplantation, having authored 416 papers that have together received 10.5k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (106 papers), Hematopoietic Stem Cell Transplantation (68 papers), Platelet Disorders and Treatments (57 papers), Acute Myeloid Leukemia Research (50 papers), Blood Coagulation and Thrombosis Mechanisms (50 papers), Hemoglobinopathies and Related Disorders (47 papers), Acute Lymphoblastic Leukemia research (36 papers) and Chronic Myeloid Leukemia Treatments (33 papers). The work is most often cited by research in Hematology (8.0k citations), Genetics (2.2k citations) and Internal Medicine (312 citations). Alok Srivastava has collaborated with scholars based in India, United States and Canada. Frequent co-authors include Mammen Chandy, Vikram Mathews, Biju George, Nigel S. Key, Johnny Mahlangu, Shaji R Velayudhan, Auro Viswabandya, Adolfo Llinás, Poonkuzhali Balasubramanian and H. Marijke van den Berg. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.